This CME-certified program includes a didactic review of the currently available data as well as Interactive Case Challenges exploring the use of recently approved antiretroviral agents in combination with existing agents to form virologically suppressive regimens for treatment-experienced patients.
Registration for this activity is open to physicians and healthcare professionals actively involved in the delivery of care to HIV-infected patients. Other restrictions may apply.
Eric S. Daar, MD
Chief, Division of HIV Medicine
Harbor-UCLA Medical Center
Professor of Medicine
David Geffen School of Medicine at UCLA
Los Angeles, California
Joseph J. Eron, Jr., MD
Professor of Medicine
University of North Carolina School of Medicine
Director, AIDS Clinical Trials Unit
Associate Director, Clinical Research Unit
University of North Carolina
Chapel Hill, North Carolina
Daniel R. Kuritzkes, MD
Director of AIDS Research
Brigham and Women's Hospital
Professor of Medicine
Harvard Medical School
Boston, Massachusetts
Edwin DeJesus, MD, FACP, AAHIVS
Medical Director
Orlando Immunology Center
Medical Director, HUG-Me Program Adult Clinic
Orlando Regional Medical Center
Orlando, Florida
Keith Henry, MD
Director, HIV Clinical Research
Hennepin County Medical Center
Professor of Medicine
University of Minnesota
Minneapolis, Minnesota
Charles B. Hicks, MD
Associate Professor of Medicine
Associate Director, Duke AIDS Research and Treatment Center
Duke University Medical Center
Durham, North Carolina
Marshall J. Glesby, MD, PhD
Associate Professor of Medicine
Co-Director, Cornell Clinical Trials Unit
Weill Medical College of Cornell University
New York, New York
Jointly sponsored by Postgraduate Institute for Medicine and Clinical Care Options, LLC.

There are no costs or fees for this educational program.